IP Library Granted Patent US 7,045,356
Granted Patent B2
US 7,045,356 · App. 10/795,679 · Granted May 16, 2006

Process for generating multilayered particles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,045,356
App. No.
10/795,679
Granted
May 16, 2006
Kind
B2
Abstract

We describe a process for generating multilayer particles comprising condensing a polymer with an oppositely charged polymer to form a particle and sequentially adding oppositely charged polymers to the particle forming at least three layers of polymers. The process is used to form a composition for delivering a biologically active compound to a cell.

Claims (26)

1. A process for delivering a polynucleotide to a cell comprising:

a) condensing a first polyanion with a polycation to form a particle;

b) adding a second polyanion to the particle to form a complex wherein at least one of the polyanions is the polynucleotide;

c) crosslinking the second polyanion to the polycation; and,

d) contacting the cell with the complex.

2. The process of claim 1 wherein condensing the first polyanion with the polycation forms a positively charged particle.

3. The process of claim 1 wherein the complex is charge neutral.

4. The process of claim 1 wherein the complex is negatively charged.

5. The process of claim 1 wherein the complex is positively charged.

6. The process of claim 1 wherein a functional group is associated with the complex.

7. The process of claim 6 wherein the functional group is selected from the list consisting of: cell targeting signals, nuclear localization signals, membrane active compounds and interaction modifiers.

8. A process for delivering a polynucleotide to a cell comprising:

a) adding a solution containing a polynucleotide to a solution containing an excess of polycation wherein the polynucleotide and the polycation interact to form a particle;

b) adding a solution containing an excess of polyanion to the particle wherein the particle and the polyanion interact to form a complex; and,

c) contacting the cell with the complex.

9. The process of claim 8 wherein the excess of polycation and the excess of polyanion are removed from the solution prior to contacting the complex with the cell.

10. The process of claim 8 wherein the polyanion is crosslinked to the polycation.

11. A complex for delivering a polynucleotide to a cell, comprising:

three or more layers of polyions of alternating charge wherein at least one of the polyions is the polynucleotide.

12. The complex of claim 11 wherein the complex comprises a condensed polycation/polyanion core complex.

13. The complex of claim 12 wherein the complex is charge neutral.

14. The complex of claim 12 wherein the complex is negatively charged.

15. The complex of claim 12 wherein the complex is positively charged.

16. The complex of claim 11 wherein at least one polyion layer is crosslinked to a successive polyion layer.

17. The complex of claim 11 wherein a functional group is associated with the complex.

18. The complex of claim 17 wherein the functional group is selected from the list consisting of: cell targeting signal, nuclear localization signal, membrane active compound and interaction modifier.